XML 37 R26.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCKHOLDERS’ DEFICIENCY (Tables)
9 Months Ended
Dec. 31, 2024
Equity [Abstract]  
SCHEDULE OF SERIES B PREFERRED STOCK FOR MEZZANINE EQUITY

A roll-forward of activity is presented below for the nine months ended December 31, 2024:

 SCHEDULE OF SERIES B PREFERRED STOCK FOR MEZZANINE EQUITY

  

Fiscal Year

2025

  

Fiscal Year

2024

 
   $   $ 
Balance beginning of period – March 31   1,488,920     
Net proceeds received pursuant to the issuance of preferred shares   1,732,532    1,900,000 
Recognition of derivative liabilities (Note 8)   (649,533)   (642,417)
Conversion into common shares   (428,722)   (228,727)
Balance end of period – December 31   2,143,197    1,028,856 
SCHEDULE OF WARRANTS OUTSTANDING

Warrant activity during the nine months ended December 31, 2024, is indicated below:

 

    Broker Warrants    

Consultant and

Noteholder

Warrants

   

Warrants Issued

on Convertible

Notes

    Total  
As at March 31, 2024     208,927       253,994       868,098       1,331,019  
                                 
Expired/cancelled           (15,000 )           (15,000 )
Exercised                        
Issued                        
As at December 31, 2024     208,927       238,894       868,098       1,316,019  
                                 
Exercise Price     $ 2.09 to $22.50       $ 2.69 to $14.40     $ 4.18          
Expiration Date     August 2026 to October 2033       March 2029 to Dec 2032       October 2027          
SCHEDULE OF STOCK OPTION ACTIVITIES

The following table summarizes the stock option activities during the nine months ended December 31:

 

   2024   2023 
  

Number of

Options

  

Weighted Average

Exercise Price

  

Number of

Options

  

Weighted Average

Exercise Price

 
                 
Outstanding at March 31, 2024   1,239,873   $9.39    1,264,890   $9.29 
Granted   291,559   $1.24    3,585   $2.79 
Exercised      $       $ 
Expired/ Forfeited   (66,719)  $12.57    (28,214)  $7.80 
Outstanding at December 31, 2024   1,464,713   $7.71    1,240,261   $9.32 
SCHEDULE OF FAIR VALUE OF OPTION GRANTED USING VALUATION ASSUMPTIONS

The fair value of each option granted is estimated at the time of grant using multi-nominal lattice model using the following assumptions, for each of the respective nine months periods ended December 31:

 

  

December 31,

2024

  

December 31,

2023

 
Exercise price ($)   0.2899 - 0.8997    2.79 
Risk free interest rate (%)   4.13% - 4.43%    3.85 
Expected term (Years)   2.00 - 6.50    10.0 
Expected volatility (%)   103.26% - 128.43%    117.1 
Expected dividend yield (%)   0.00    0.00 
Fair value of option ($)   0.178 - 0.733    2.30 
Expected forfeiture (attrition) rate (%)   0.00    0.00